Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

PlusUltra's profile

Predictions
Pharvaris N.v.

Start price
Target price
Perf. (%)
€16.10
09.01.22
-
09.01.23
-6.83%

Capable Management
Probably not worthwhile Investment
High valuation
Below average Marketposition
buy
Royalty Pharma Plc

Start price
Target price
Perf. (%)
€36.60
26.12.21
-
26.12.22
-5.46%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Undervalued
Very capable Management
Blog